Cargando…

A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy

Tacrolimus is an immunosuppressive agent for acute rejection after allotransplantation. However, the low aqueous solubility of tacrolimus poses difficulties in formulating an injection dosage. Polypeptide thermosensitive hydrogels can maintain a sustained release depot to deliver tacrolimus. The cop...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hsiu-Chao, Anggelia, Madonna Rica, Cheng, Chih-Chi, Ku, Kuan-Lin, Cheng, Hui-Yun, Wen, Chih-Jen, Wang, Aline Yen Ling, Lin, Cheng-Hung, Chu, I-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723608/
https://www.ncbi.nlm.nih.gov/pubmed/31416239
http://dx.doi.org/10.3390/pharmaceutics11080413
_version_ 1783448809193340928
author Lin, Hsiu-Chao
Anggelia, Madonna Rica
Cheng, Chih-Chi
Ku, Kuan-Lin
Cheng, Hui-Yun
Wen, Chih-Jen
Wang, Aline Yen Ling
Lin, Cheng-Hung
Chu, I-Ming
author_facet Lin, Hsiu-Chao
Anggelia, Madonna Rica
Cheng, Chih-Chi
Ku, Kuan-Lin
Cheng, Hui-Yun
Wen, Chih-Jen
Wang, Aline Yen Ling
Lin, Cheng-Hung
Chu, I-Ming
author_sort Lin, Hsiu-Chao
collection PubMed
description Tacrolimus is an immunosuppressive agent for acute rejection after allotransplantation. However, the low aqueous solubility of tacrolimus poses difficulties in formulating an injection dosage. Polypeptide thermosensitive hydrogels can maintain a sustained release depot to deliver tacrolimus. The copolymers, which consist of poloxamer and poly(l-alanine) with l-lysine segments at both ends (P–Lys–Ala–PLX), are able to carry tacrolimus in an in situ gelled form with acceptable biocompatibility, biodegradability, and low gelling concentrations from 3 to 7 wt %. By adding Pluronic F-127 to formulate a mixed hydrogel system, the drug release rate can be adjusted to maintain suitable drug levels in animals with transplants. Under this formulation, the in vitro release of tacrolimus was stable for more than 100 days, while in vivo release of tacrolimus in mouse model showed that rejection from skin allotransplantation was prevented for at least three weeks with one single administration. Using these mixed hydrogel systems for sustaining delivery of tacrolimus demonstrates advancement in immunosuppressive therapy.
format Online
Article
Text
id pubmed-6723608
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67236082019-09-10 A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy Lin, Hsiu-Chao Anggelia, Madonna Rica Cheng, Chih-Chi Ku, Kuan-Lin Cheng, Hui-Yun Wen, Chih-Jen Wang, Aline Yen Ling Lin, Cheng-Hung Chu, I-Ming Pharmaceutics Article Tacrolimus is an immunosuppressive agent for acute rejection after allotransplantation. However, the low aqueous solubility of tacrolimus poses difficulties in formulating an injection dosage. Polypeptide thermosensitive hydrogels can maintain a sustained release depot to deliver tacrolimus. The copolymers, which consist of poloxamer and poly(l-alanine) with l-lysine segments at both ends (P–Lys–Ala–PLX), are able to carry tacrolimus in an in situ gelled form with acceptable biocompatibility, biodegradability, and low gelling concentrations from 3 to 7 wt %. By adding Pluronic F-127 to formulate a mixed hydrogel system, the drug release rate can be adjusted to maintain suitable drug levels in animals with transplants. Under this formulation, the in vitro release of tacrolimus was stable for more than 100 days, while in vivo release of tacrolimus in mouse model showed that rejection from skin allotransplantation was prevented for at least three weeks with one single administration. Using these mixed hydrogel systems for sustaining delivery of tacrolimus demonstrates advancement in immunosuppressive therapy. MDPI 2019-08-14 /pmc/articles/PMC6723608/ /pubmed/31416239 http://dx.doi.org/10.3390/pharmaceutics11080413 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lin, Hsiu-Chao
Anggelia, Madonna Rica
Cheng, Chih-Chi
Ku, Kuan-Lin
Cheng, Hui-Yun
Wen, Chih-Jen
Wang, Aline Yen Ling
Lin, Cheng-Hung
Chu, I-Ming
A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy
title A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy
title_full A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy
title_fullStr A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy
title_full_unstemmed A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy
title_short A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy
title_sort mixed thermosensitive hydrogel system for sustained delivery of tacrolimus for immunosuppressive therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723608/
https://www.ncbi.nlm.nih.gov/pubmed/31416239
http://dx.doi.org/10.3390/pharmaceutics11080413
work_keys_str_mv AT linhsiuchao amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT anggeliamadonnarica amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT chengchihchi amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT kukuanlin amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT chenghuiyun amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT wenchihjen amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT wangalineyenling amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT linchenghung amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT chuiming amixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT linhsiuchao mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT anggeliamadonnarica mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT chengchihchi mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT kukuanlin mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT chenghuiyun mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT wenchihjen mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT wangalineyenling mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT linchenghung mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy
AT chuiming mixedthermosensitivehydrogelsystemforsustaineddeliveryoftacrolimusforimmunosuppressivetherapy